Nicola Fusco, Director of the Division of Pathology at IEO European Institute of Oncology, shared a post on LinkedIn:
“SABCS2025 wrapped up, and it was inspiring.
Grateful to have contributed this year with a symposium, together with Elena Guerini Rocco and John Longshore discussing the real-world value of pragmatic NGS testing for ESR1 on liquid biopsy.
The new oral SERDs need robust, accessible molecular tests to change practice.
Equally proud of the poster by Konstantinos Venetis and Antonio Marra on ctDNA-detected co-mutational patterns in HR+/HER2− metastatic breast cancer, helping to inform smarter treatment sequencing.
This is how progress happens.
Through teamwork.
Through mentorship.
Through serving patients.”
More posts featuring Nicola Fusco.
